Market Cap 129.99M
Revenue (ttm) 10.22M
Net Income (ttm) -20.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -202.25%
Debt to Equity Ratio 0.00
Volume 18,500
Avg Vol 63,032
Day's Range N/A - N/A
Shares Out 21.77M
Stochastic %K 17%
Beta 2.51
Analysts Strong Sell
Price Target $16.00

Company Profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatit...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 564 9244
Address:
750 West Pender Street, Suite 1200, Vancouver, Canada
SuperGreenToday
SuperGreenToday May. 1 at 2:24 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 30 at 11:53 PM
$ACOG RSI: 48.86, MACD: 0.0866 Vol: 0.39, MA20: 6.50, MA50: 6.06 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 28 at 9:40 PM
$ACOG https://www.businesswire.com/news/home/20260428200818/en/Alpha-Cognition-Nasdaq-ACOG-to-Report-First-Quarter-2026-Financial-Results-and-Provide-Business-Update-on-Thursday-May-14-2026 -Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, May 14, 2026, at 4:30 p.m. ET, after market close- - The live audio webcast will be accessible here: https://viavid.webcasts.com/starthere.jsp?ei=1761279&tp_key=1a22b7db8e
1 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 27 at 11:06 PM
$ACOG https://www.businesswire.com/news/home/20260427777982/en/Alpha-Cognition-Inc.-to-Participate-in-Three-Upcoming-Investor-Conferences
0 · Reply
Bioinvester001
Bioinvester001 Apr. 22 at 6:18 PM
$ACOG New board member has BO experience and skills. McFadden playbook in motion here. Looking for a grind up in the sp to earnings date.
0 · Reply
gnarled15
gnarled15 Apr. 20 at 12:34 PM
$ACOG 😁 $7 🤫
0 · Reply
JackCampbell
JackCampbell Apr. 17 at 7:42 PM
$ACOG Craig-Hallum initiated coverage on Alpha Cognition Inc (NASDAQ:ACOG) with a buy rating and a price target of $14.00, the firm said Thursday.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 16 at 8:11 PM
$ACOG https://www.businesswire.com/news/home/20260415562909/en/Alpha-Cognition-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
0 · Reply
JackCampbell
JackCampbell Apr. 8 at 9:35 AM
$ACOG very
0 · Reply
RafaelTheOne
RafaelTheOne Apr. 7 at 7:06 PM
0 · Reply
Latest News on ACOG
Alpha Cognition Earnings Call Transcript: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 5 weeks ago

Alpha Cognition Earnings Call Transcript: Q4 2025


Alpha Cognition Transcript: Fireside Chat

Dec 2, 2025, 12:00 PM EST - 5 months ago

Alpha Cognition Transcript: Fireside Chat


Alpha Cognition Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

Alpha Cognition Earnings Call Transcript: Q3 2025


Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

Oct 6, 2025, 8:30 AM EDT - 7 months ago

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting


Alpha Cognition Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 9 months ago

Alpha Cognition Earnings Call Transcript: Q2 2025


Alpha Cognition Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings Call Transcript: Q1 2025


Alpha Cognition Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Alpha Cognition Earnings Call Transcript: Q4 2024


Alpha Cognition Transcript: Investor Update

Jan 28, 2025, 4:00 PM EST - 1 year ago

Alpha Cognition Transcript: Investor Update


CSE Bulletin: Delist - Alpha Cognition Inc. (ACOG)

Dec 16, 2024, 11:51 AM EST - 1 year ago

CSE Bulletin: Delist - Alpha Cognition Inc. (ACOG)


Alpha Cognition Announces Voluntary Delisting from CSE

Dec 12, 2024, 6:41 PM EST - 1 year ago

Alpha Cognition Announces Voluntary Delisting from CSE


SuperGreenToday
SuperGreenToday May. 1 at 2:24 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 30 at 11:53 PM
$ACOG RSI: 48.86, MACD: 0.0866 Vol: 0.39, MA20: 6.50, MA50: 6.06 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 28 at 9:40 PM
$ACOG https://www.businesswire.com/news/home/20260428200818/en/Alpha-Cognition-Nasdaq-ACOG-to-Report-First-Quarter-2026-Financial-Results-and-Provide-Business-Update-on-Thursday-May-14-2026 -Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, May 14, 2026, at 4:30 p.m. ET, after market close- - The live audio webcast will be accessible here: https://viavid.webcasts.com/starthere.jsp?ei=1761279&tp_key=1a22b7db8e
1 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 27 at 11:06 PM
$ACOG https://www.businesswire.com/news/home/20260427777982/en/Alpha-Cognition-Inc.-to-Participate-in-Three-Upcoming-Investor-Conferences
0 · Reply
Bioinvester001
Bioinvester001 Apr. 22 at 6:18 PM
$ACOG New board member has BO experience and skills. McFadden playbook in motion here. Looking for a grind up in the sp to earnings date.
0 · Reply
gnarled15
gnarled15 Apr. 20 at 12:34 PM
$ACOG 😁 $7 🤫
0 · Reply
JackCampbell
JackCampbell Apr. 17 at 7:42 PM
$ACOG Craig-Hallum initiated coverage on Alpha Cognition Inc (NASDAQ:ACOG) with a buy rating and a price target of $14.00, the firm said Thursday.
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 16 at 8:11 PM
$ACOG https://www.businesswire.com/news/home/20260415562909/en/Alpha-Cognition-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
0 · Reply
JackCampbell
JackCampbell Apr. 8 at 9:35 AM
$ACOG very
0 · Reply
RafaelTheOne
RafaelTheOne Apr. 7 at 7:06 PM
0 · Reply
SocioCobb
SocioCobb Apr. 7 at 3:14 PM
$ACOG watching this closely. Sitting at a critical resistance/support level. Close here or higher wpuld be bullish for continuing gains. S4 Open matket about 8 mos ago 20% higher- hmmmm
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 3 at 5:18 PM
Investor AI Fund early signals are firing ⚡ 👉Click to view @NasdaqPulse for timely updates amid the volatility. Desk 1 (Insider Intelligence) is already spotting strength with $ACOG +18.6% and $TGEN +14.1% leading the charge — early alpha showing up fast. But Desk 2 (Options Flow Hunter) is waving caution flags as $TTD slips -3.1%, hinting at weakening momentum under the surface. This is where it gets interesting: signal confluence is kicking in, forcing systematic rebalancing across desks. Strength gets rotated into, weakness gets cut — no emotions, just data. Smart money isn’t guessing… it’s adapting in real time. All eyes on the system as we track positioning ahead of the April launch
0 · Reply
FlowerInTheCellar
FlowerInTheCellar Apr. 2 at 7:35 AM
$ACOG https://www.businesswire.com/news/home/20260401736131/en/Alpha-Cognition-Receives-Issued-U.S.-Patent-for-ALPHA-1062-for-Treatment-of-Traumatic-Brain-Injury
0 · Reply
focafoca99
focafoca99 Apr. 1 at 9:51 PM
$ACOG picked up a new U.S. patent around ALPHA-1062 for traumatic brain injury, which helps extend the IP story beyond Alzheimer's.
0 · Reply
jumptime
jumptime Apr. 1 at 9:33 PM
$ACOG BRIEF-Alpha Cognition Receives Issued U.S. Patent For Alpha-1062 For Treatment Of Traumatic Brain Injury
0 · Reply
LewisDaKat
LewisDaKat Apr. 1 at 7:00 PM
$ACOG Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 https://marketwirenews.com/stock/acog/news/stonegate-capital-partners-updates-coverage-on-alpha-5505211532967784.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Apr. 1 at 6:30 PM
$ACOG Alpha Cognition (ACOG) Q4 2025 Earnings Transcript https://marketwirenews.com/stock/acog/news/alpha-cognition-acog-q4-2025-earnings-transcript-6348690691221924.html?utm_source=stocktwits
0 · Reply
newsfile_corp
newsfile_corp Apr. 1 at 1:52 PM
https://nfne.ws/290861 $ACOG @reportablenews #NASDAQ #Investing
0 · Reply
Bioinvester001
Bioinvester001 Mar. 31 at 5:02 PM
$ACOG Sleep disorders is the new big pharma focus. Acog addresses this with it's ALZ drug, and look for more interest in the company.
0 · Reply
jumptime
jumptime Mar. 31 at 3:04 PM
$ACOG Volume...
0 · Reply
rombrento
rombrento Mar. 30 at 9:47 PM
0 · Reply
theflynews
theflynews Mar. 30 at 4:21 PM
Biotech Alert: Searches spiking for these stocks today - $ACOG - https://thefly.com/ACOG
0 · Reply